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The effect of artificial model membranes on the complement system was investigated. Incubation of the 
model membranes with human serum resulted in consumption of complement haemolytic activity when 
phosphatidylserine-containing vesicles were used. The activation of the complement system appeared to 
proceed through the alternative pathway. This conclusion was supported by the failure of [12sI]Clq to bind 
to the membranes uggesting that the classical pathway was not involved. Although always obtained when 
phosphatidylse~ne was present in the model membrane, the activation of complement was enhanced by 
the contem~raneous presence of phosphatidylethanolamine. Liposomes prepared from lipid extracts of red 
blood cells were also able to stimulate a concentration-dependent activation of complement. Fresh, intact 
erythrocytes, however, could not initiate the same effects unless opsonized by antibodies. When artificially 
aged in vitro, red blood cells were lysed if incubated with normal human serum or with Clq-depleted serum. 
However, no lysis was obtained if the ‘aged’ erythrocytes were incubated with serum pretreated with ammo- 
nia to destroy the C3 component of complement. It is suggested that one of the mechanisms of macrophage 
recognition of senescent erythrocytes might be provided by the activation of the alternative pathway of com- 
plement if phosphatidylserine becomes exposed on the surface of the aging cells. 
Complement activation Phospholipid 
1. INTRODUCTION 
Macrophages routinely phagocytose erythro- 
cytes at the end of their 120-day lifespan [l]. The 
ability of macrophages to selectively recognize, 
and remove from the blood stream, cells that are 
no longer functional, while leaving the mature 
viable cells unharmed, has been attributed to bin- 
ding of antibodies, opsonizing erythrocytes, by the 
Fc receptors on the surface of macrophages [2]. 
Very little is known about the mechanism 
employed but probably the recognition of aged 
erythrocytes by the macrophages involves the 
removal of sialic acid from their cell surface. 
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Erythrocyte Membrane asymmetry 
Evidence for this includes the demonstration that 
neuraminidase treatment of erythrocytes led to a 
decreased survival time of the cells when they were 
injected into an animal’s circulation 131. However, 
other investigations have also shown significant 
age-related alterations in the structure and func- 
tion of membrane components of human 
erythrocytes, including decrease in membrane 
deformability [4] and phospholipid concentrations 
151. Stuart and Cummings [6] have suggested that 
the elimination of senescent erythrocytes from the 
peripheral circulation is related to such changes 
and is mediated by the deposition of normal 
human serum components. This has been sup- 
ported by results presented by Alderman et al. [2] 
indicating that upon removal of sialic acid, IgG 
binds to the newly exposed antigens on the surface 
of senescent cells, but not younger erythrocytes. 
Macrophages would then recognize the opsonized 
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RBC via the Fe receptors and phagocytose them. 
Recently, the asymmetric distribution of 
phospholipids in RBC membranes has been im- 
plicated in the recognition system [7]. Of the four 
major phospholipids of the erythrocyte mem- 
brane, phosphatidylserine (PS) is found nearly ex- 
cIusively on the cytoplasmic surface [8] while the 
outer monolayer of the membrane is rich in neutral 
phospholipids, particularly sphingomyelin (SM) 
with phosphatidylcholine (PC) and phosphatidyI- 
ethanol~ine (PE) present on both membrane 
sides though not to the same extent. Abnormaiities 
in the lipid distribution in membranes have already 
been associated with bioIogica1 phenomena, such 
as platelet aggregation 191, cell transformation [IO] 
and sickle cell anaemia [ll]. The outer surface of 
sickle cells, for example, has been found to be 
enriched in PE and PS, compared with the normal 
RBC [ 121. These changes were bafanced by the 
decrease in PC in that layer. 
Recently, negatively charged vesicles composed 
of PS and PC were found to bind to macrophage 
and be phagocytosed at significantly higher rates 
than neutral vesicles composed exclusively of PC 
f13]. In view of this, PS has been suggested to pro- 
vide a signal that triggers macrophage recognition 
[14]. Although the nature of the signal has not 
been established, direct interaction of the 
macrophages with PS or indirect action via 
protein-iridependent PS-Ca” interactions [15] 
have been proposed. However, in view of the 
reported damage to Forssman antigen-bearing 
liposomes by complement, or complement- 
mediated lysis of antigen-free liposomes [16,171 we 
decided to explore a possible role of antibody- 
independent serum complement activation in the 
macrophage recognition of senescent celfs. 
2. MATERIALS AND METHODS 2.4. Lipid vesicle preparations 
Ovalbumin, egg phosphatidylcholine (in 
CHCU egg phosphatidylethanolamine (in 
CHCI3), bovine brain phosphatidyl-L-serine, and 
bovine brain sphingomyelin were purchased from 
Sigma, St. Louis, MO. Sheep erythrocyte an- 
tiserum (haemolysin) was purchased from the 
Commonwealth Serum Laboratory, Melbourne, 
Australia. Normal human serum was supplied by 
the Red Cross BIood Bank, Sydney, Austratia. 
Human Clq was isolated from serum, and labelled 
with “‘1 using lactoperoxidase [181, Rabbit IgG 
was prepared according to Wilkinson [19]. 
Equivalence ovalbumin-antiovalbumin rabbit IgG 
immune complexes were prepared as described by 
Sutton et al. 1201. 
2.2. Human sera 
Human serum depleted in complement compo- 
nent C3 and C4 was prepared as described by 
Lachmann et al. IZOa]. Normal human serum was 
depleted of Clq by adsorption with an equal 
volume of antiovalbumin immune compfexes 
(1 mg/ml) in the presence of 0.01 M EDTA ac- 
cording to Barbaro [Zl]. Control serum was 
diluted 1:2 with 10 mM phosphate, 150 mM 
NaCl, pH 7.2 (PBS), containing 0.02 M EDTA 
and, except for adsorption, was similarly treated. 
After the treatment, 0.01 M CaClz was added to 
the serum to neutralize the effect of EDTA. 
2.3. ~xfrac~~on of lipid from er~~~~~c~~e 
~e~~ra~e~ 
Human erythrocyte ghosts were prepared by 
hypotonic iysis of erythrocytes at 4’C followed by 
4-5 washes with lysis buffer (5 mM sodium 
phosphate, pH 8) according to standard methods. 
The membrane lipids were extracted by shaking the 
erythro~yte ghost membranes with a mixture of 
methanol:chloroform (2: 1) for 15 min. 1 ml 
chloroform and 1 ml water were then added per ml 
of ghosts, and shaken again to separate the two 
liquid phases. After centrifugation (3000 x g, 
10 min), the bottom chloroform fayer was col- 
lected and the solvent evaporated in vacua at 
37°C. The lipids were finally dissolved in 
chloroform : methanol (2 : 1, v/v). 
The lipid vesicles were prepared from total lipid 
extract of erythrocyte membranes or from 
phospholipids mixed in different proportions. 
Chloroform was evaporated under a nitrogen 
stream leaving the lipids as a thin film in a flask. 
In order to ensure complete removal of the solvent, 
the film was left under vacuum at least I h. The 
lipids were suspended by shaking on a vortex mixer 
in PBS to obtain a lipid concentration of 14 mg/ml 
and the suspension left at 37°C for 10 min. The 
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milky suspension was sonicated at 4°C under 
nitrogen for 2 h with a Branson B15 sonifier, 
equipped with a micro-tip probe and tuned for 
maximum power output. After sonication, 
titanium fragments released from the sonication 
probe and any undispersed phospholipid were 
removed by centrifugation (30000 x g for 60 min). 
The preparations were then chromatographed on a 
Sepharose 4B column. Since Sepharose adsorbs 
lipids, the column was pre-equilibrated with PC 
vesicles prepared by the same method to avoid 
large losses. An upward flow rate of 0.3 mllmin 
was used and the eluate was monitored by the tur- 
bidity measured at 300 nm. 
2.5. In vitro aging of erythrocytes 
Erythrocytes were aged in vitro by washing them 
3 times with 0.1 M phosphate buffered saline, pH 
7.4, and storing them for 2 weeks at 4°C. 
2.6. Complement haemolytic activity 
Normal human serum was desensitized by 3 
cycles of adsorption against sheep erythrocytes. 
Desensitized serum (0.4 ml, 1: 10 dilution) was in- 
cubated at 37°C for 30 min in the presence of the 
appropriate phospholipid preparation (0.2 mg) in 
barbitone buffered saline (BBS) containing MgCl2 
and CaCl2 [22] in a final volume of 0.5 ml. 
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Fig. 1. Gel filtration of a typical sonicated phospholipid 
vesicle preparation on a Sepharose 4B column (1 x 
90 cm). The column was pre-equilibrated with a 
phosphatidylcholine preparation and eluted with PBS. 
The turbidity of the eluate was monitored at 300 nm 
(O--O). When [12sI]Clq was preincubated with the 
vesicle suspensions, its elution was followed by the 
radioactivity associated with the protein (a---e). 
Haemolysin-activated sheep erythrocytes (2.5 x 
10’ cells, 0.1 ml) were then added and after 1 h in- 
cubation at 37”C, the non-damaged cells were 
spun down at 3000 x g for 5 min at 4°C. The 
residual complement activity of the serum was 
determined from the extent of lysis of the cells 
measured by the absorbance at 541 nm. Spon- 
taneous haemolysis control (sensitized RBC + 
BBS) and complement activity control (sensitized 
RBC + normal serum + BBS) were included in 
each set of experiments. When the haemolytic ac- 
tivity of serum was tested against fresh or ar- 
tificially aged RBC, the appropriate erythrocyte 
suspension (2.5 x 10’ cells, 0.1 ml) was incubated 
with 0.5 ml of normal human serum or with serum 
depleted of the Clq or the C3 components of com- 
plement (1: 10 dilution). The extent of cell lysis 
after 1 h incubation at 37°C was monitored as 
above. 
3. RESULTS 
The basic procedure used in preparing the 
phospholipid vesicles was essentially identical to 
the method described by Huang and Thompson 
1231 for the preparation of egg phosphatidylcho- 
line vesicles. Experimental evidence obtained using 
a variety of techniques has shown that phospho- 
lipid liposomes obtained by prolonged ultrasonic 
irradiation in dilute aqueous buffers are almost ex- 
clusively composed of vesicles, each comprised of 
a single continuous bimolecular lipid layer [24,25]. 
Fig.1 shows the elution profile of freshly 
sonicated lipid vesicle suspensions chromato- 
graphed on a Sepharose 4B column. Two peaks 
were obtained: a small void volume peak con- 
taining all larger liposomes that did not penetrate 
into the Sepharose gel and a single large, but sym- 
metrical, peak containing the smaller more homo- 
geneously sized liposomes [23]. Binding of 
[ “‘I]C 1 q to the vesicle preparations was attempted 
by incubating the protein with the freshly soni- 
cated vesicles for 1 h at 25°C before the chro- 
matographic step. As shown by the gel filtration 
elution profile (fig. l), however, no radioactivity 
was found to be associated with either of the two 
lipid fractions. [‘2’I]Clq eluted later in a clear 
fraction indicating no association with the phos- 
pholipid fraction used (peak II) in our experi- 
ments. 
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The abihty of the vesicles to trigger the comple- 
ment system was tested by measuring the residual 
complement activity of serum samples prein- 
cubated with the preparations at 37°C for 30 min. 
The vesicles depleted serum haemolytic activity ac- 
cording to the relative ratio of the three individual 
phospholipids used in the preparations: PC, PE 
and PS (fig.2). The haemolytic activity of comple- 
ment was found to be inhibited when PS was used 
in the preparation of the vesicles. This effect was 
found to be enhanced by the simultaneous 
presence of PE. 
The effect of temperature on the preincubation 
of the vesicles with serum was also investigated by 
incubating the vesicles with serum on ice or in a 
water bath at 37°C. About 25% of the haemolytic 
activity was consumed by a 3 min incubation at 
37”C, and almost 90% depletion was achieved by 
30 min, whereas no consumption of complement 
was observed in the sample kept cold (fig.3). 
Lipid vesicIes obtained from an extract of 
erythrocyte ghost membrane lipids were also able 
to inhibit the complement haemolytic activity of 
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Fig.2. Residual haemolytic activity of human serum 
preincubated with lipid vesicles. The vesicles were 
prepared with PC:PE, 9: 1, w/w (m---m); PC:PS, 9: 1, 
w/w (o--- 0); or PC:PE:PS, 8: 1: 1, w/w (&--A) and 
incubated with various amounts of normat human 
serum. The residual complement activity of serum was 
then determined as described in section 2. Serum 
preincubated with barbitone buffer was used as a control 
(o---o). 
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Fig.3. Temperature dependence of complement 
haemolytic activity inhibition of phospholipid vesicles, 
The vesicles were prepared with PC : PE: PS (8 : 1 : I, 
w/w) and incubated with serum at 4°C (O--O) or at 
37’C (o-----a). The residual complement activity of 
serum was determined as described in section 2. 
1 
Fig.4. Residual haemolytic activity of serum 
preincubated with lipid vesicles prepared from 
phosphoiipids extracted from erythrocyte membranes. 
The residual haemolytic activity of 0.4 ml normal 
human serum was determined after preincubation with 
various amounts of lipid vesicles as described in section 
2. 
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serum as shown by the concentration-dependent 
inhibition of such a preparation (fig.4). 
We also prepared lipid vesicles with a 
phospholipid composition similar to that of the 
outer layer of RBC membrane (44% PC, 12% PE, 
44% SM and no PS) and that of the inner layer 
(15070 PC, 47% PE, ItHo SM and 28% PS) and 
determined the effect of such vesicles on serum 
complement haemolytic activity. The results of 
these experiments are shown in table 1. Vesicles 
with a phospholipid composition similar to the 
outer layer of the erythrocyte membrane did not 
significantly decrease the haemolytic activity of 
serum after 1 h incubation. in contrast, vesicles 
with phospholipid composition similar to the inner 
surface of erythrocytes, considerably inhibited the 
serum haemolytic activity. 
When freshly isolated, intact, unsensitized 
erythrocytes were exposed to normal human 
serum, no significant lysis was observed. On the 
other hand, when artificially aged cells were ex- 
posed to the same serum, up to 28% lysis was 
recorded at optimal concentrations (fig.5). The 
data obtained suggest hat a structural change took 
place in about 28% of the cells after incubation for 
2 weeks, and that this change made the cells 
vulnerable to serum-mediated damage. Cl q- 
adsorbed serum was equally effective in lysing the 
erythrocytes indicating that Clq was not required, 
for recognition of surface antigens, by the comple- 
Table 1 
Residual haemolytic activity of lipid vesicles incubated 
with normal human serum 
Phospholipid Residual haemolytic 
preparation activity (o/o) 
PC 96 
PC: PE (90: 10) 93 
PC:PS (90: 10) 64 
PC:PE:PS (80: IO: 10) 7 
PC:PE:SM (44:12:44) 88 
PC:PE:SM:PS (15:47:10:28) 2 
RBC lipid extract 19 
The weight ratio of phosphoiipids used in the 
preparations is shown in parentheses. The residuaf 
haemolytic activity of 0.4 ml serum (1: 10 dilution) was 
determined after preincubation with 0.1 mg phospho- 
lipid preparation as described in section 2 
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Fig.5. Lytic activity of serum against er~hr~ytes. Fresh 
(G-Q) or artificially aged (M) erythrocytes were 
incubated with normal human serum as described in 
section 2. Artificially aged cells were also incubated with 
Clq-depleted (H) or with C3-depleted serum 
(S). 
ment system. This excludes the involvement of the 
classical pathway. In contrast, C3-depleted serum 
was unable to display the same lytic activity, im- 
plying that the alternative pathway of complement 
might have been responsible for the observed cell 
damage. This suggests that the recognition of 
senescent cells by macrophages in vivo may be in- 
itiated by binding of C3b fragments, formed dur- 
ing activation of the alternative pathway, to their 
receptors on the surface of macrophages. 
4. DISCUSSION 
The results of our study indicate that 
phospholipid vesicles displaying PS and PE on 
their surface are able to activate the alternative 
pathway of complement in human serum. 
Recently, Tanaka and Schroit [7] have reported 
interaction of isolated macrophages with RBC 
displaying PS in their surface membrane. 
Although phagocytosis was implied, the method 
employed was unsatisfactory because it only 
measured attachment o the cells and phag~~osis 
did not necessarily follow. A more recent paper by 
Schroit et al. [14], however, has confirmed that ad- 
dition of PS to RBC enhances their recognition by 
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macrophages resulting in phagocytosis. The ex- 
periments, in this case, were performed in vivo and 
hence, in the presence of serum proteins. 
Significant differences in the distribution of PS 
in RBC has been suggested to play a physiological 
role in the maintenance of homeostasis [7]. 
Although no such differences have been found in 
a normal population of erythrocytes, the proposal 
is still valid because, as suggested by Schroit et al. 
[ 141, one would not expect to find transformed old 
cells in peripheral blood because they would be 
rapidly removed from circulation by phagocytic 
cells. 
However, abnormal organization of amino- 
phospholipids has been demonstrated within the 
lipid bilayer of sickled erythrocytes [12]. The most 
notable change that occurred during sickling was 
the translocation of PE and PS from the inner to 
the outer lipid bilayer. Lipid asymmetry caused by 
hypoxia-induced sickling in erythrocytes, causes 
the sickle cells to bind avidly to human monocytes. 
In contrast, oxygenated sickled cells, which are 
morphologically normal in appearance and do not 
express PS on their outer surface, do not bind to 
the monocytes [7]. 
The factors controlling the rearrangements of 
phospholipids within the lipid bilayer during sick- 
ling are unknown although it has been suggested 
that spectrin may play an important role in 
stabilizing membrane phospholipid distribution in 
human erythrocytes [26]. Spectrin has been shown 
to be irreversibly deformed in irreversible sickle 
cells [27]. 
The results of our experiments using artificial 
phospholipid vesicles support the possibility that 
PS in exposed membrane surfaces may promote 
serum complement activation, which would then 
probably mediate biological effects, such as 
macrophage recruitment. The results of ex- 
periments on the effect of preincubation 
temperature of the vesicles with serum 
demonstrated that activation was not caused by 
non-specific adsorption of complement com- 
ponents, as shown by the lack of lytic inhibition 
when the preincubation was performed at 4°C. 
Although other explanations are possible, it is 
feasible that the observed complement activation 
by PS/PE in artificial vesicles may also be respon- 
sible for the observed damage to the artificially 
aged RBC if PS and/or PE become exposed on the 
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cell surface after losing enough sialic acid residues. 
The alternative pathway of complement seems 
to be involved in the activation process because 
Clq was shown not to bind to the vesicle prepara- 
tions. These results are in agreement with the 
observation that sheep erythrocytes are able to ac- 
tivate the alternative pathway of complement when 
sialic acids are removed from their surface [28]. In 
addition, artificially aged RBC were damaged by 
Clq-adsorbed serum but not by C3-depleted 
serum. 
The presence of complement-activating phos- 
pholipids only at cytoplasmic surfaces of RBC is 
not only consistent with phospholipid asymmetry 
in membranes, but might also serve an important 
biological purpose. It could be judged as poten- 
tially dangerous to have complement-activating 
phospholipids at the outer surface of blood cells, 
which would bring about immediate lysis. This fact 
itself could provide one of the physiological 
reasons for an asymmetric phospholipid distribu- 
tion in RBC membranes. 
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